Page last updated: 2024-10-28

hydroxychloroquine and Cardiac Conduction Defect

hydroxychloroquine has been researched along with Cardiac Conduction Defect in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
" Hydroxychloroquine (HCQ)-associated cardiovascular adverse events (CVAEs) have been increasingly reported."1.72An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19. ( Li, Y; Luo, M; Wu, B; Wu, F, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Luo, M1
Wu, B1
Li, Y1
Wu, F1
ORTOLANI, G1
GIULIANI, V1
ELISEO, V1

Other Studies

2 other studies available for hydroxychloroquine and Cardiac Conduction Defect

ArticleYear
An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19.
    International journal of clinical pharmacy, 2022, Volume: 44, Issue:5

    Topics: Arrhythmias, Cardiac; Bradycardia; Cardiac Conduction System Disease; Cardiovascular System; COVID-1

2022
[Chloroquine and hydroxychloroquine in the therapy of arrhythmia due to fibrillation].
    La Riforma medica, 1963, Mar-02, Volume: 77

    Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Chloroquine; Heart Conduc

1963